Skip To Main Content
Kelera Matavesi on Muck Rack

Kelera Matavesi

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kelera

Contact Kelera, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Scabies and impetigo prevalence following ivermectin-based mass drug administration campaigns in Solomon Islands and Fiji

|
By Hannah Andrews, Susanna J. Lake, Sarah Wamala Andersson, Julie Zinihite, Matthew G. Parnaby, Tessa Hughes, Anneke Grobler, Daniel Engelman, Lucia Romani, Mike Kama, John M Kaldor, Oliver Sokana, Andrew Steer, Aminiasi Tavui, Kelera Matavesi, Aminiasi Koroivueta, Josefa Koroivueta, Rejieli Vuniduvu, Mareta Vuki, Varanisese Rosa, June Tavalia, Ayleen Sosopu, Johnina Huniehu, Sanira Ghemu, Donald Rotu, Meciusela Tuicakau, Aalisha Sahukhan
| Nature Verified
Abstract Scabies is a neglected tropical skin disease that is endemic in Pacific Island countries. Ivermectin-based mass drug administration (MDA) trials have led to reductions in scabies and impetigo prevalence. The World Scabies Program supported ministries of health with national scabies MDA campaigns in Solomon Islands (two annual rounds, 2022–2024) and Fiji (one round, 2022).
Open in Who Shared Issue with article?
See all 1 articles